Summary of complications during the follow-up period
| Adverse Events | At Discharge (n = 52 cases) | Ratio | 3-Month Follow-Up (n = 43 cases) | Ratio | 12-Month Follow-Up (n = 36 cases) | Ratio |
|---|---|---|---|---|---|---|
| Hemorrhagic | 0 | 0.0% | 1 | 2.3% | 0 | 0.0% |
| Thromboembolic, symptomatic | 1 | 1.9% | 0 | 0.0% | 1 | 2.8% |
| Thromboembolic, asymptomatic | 3 | 5.7% | 2 | 4.7% | 1 | 2.8% |
| Total | 4 | 7.6% | 3 | 7.0% | 2 | 5.6% |